|
CN112280862A
|
|
Marker group for predicting curative effect of immunotherapy on nasopharyngeal carcinoma and application thereof
|
|
CN111671909A
|
|
Application of statins combined with ROR agonist in aspect of treating colorectal cancer
|
|
CN111739033A
|
|
Method for establishing breast molybdenum target and MR image omics model based on machine learning
|
|
CN111739640A
|
|
Risk prediction system based on mammary gland molybdenum target and MR image imaging omics
|
|
CN111999499A
|
|
Marker for predicting nasopharyngeal carcinoma metastasis risk and application thereof
|
|
CN111437389A
|
|
Composition for cancer radiotherapy sensitization and application thereof
|
|
CN111826412A
|
|
Method for high-throughput detection of EB virus infection efficiency/EB virus infection blocking efficiency by antibody
|
|
CN111558044A
|
|
Pharmaceutical composition containing sunitinib, and preparation and application thereof
|
|
CN111518909A
|
|
Application of METTL2 gene in preparation of kit for detecting colorectal cancer fluorouracil drug treatment sensitivity
|
|
CN111714629A
|
|
Application of medicine composition in preparing medicine for treating tumor insensitive to PD-1 antibody immunotherapy
|
|
CN111548411A
|
|
Monoclonal antibody for neutralizing EB virus and application thereof
|
|
CN111574621A
|
|
Monoclonal antibody for neutralizing EB virus and application thereof
|
|
CN111358952A
|
|
Anti-tumor pharmaceutical composition, preparation and application thereof
|
|
CN111575236A
|
|
Preparation method of human liver cancer tissue and liver tissue active single cell suspension
|
|
CN111370067A
|
|
LC/GC-MS-oriented metabonomics data quality control method and system
|
|
CN111407894A
|
|
Novel combined targeted drug for treating relapsed/refractory T cell lymphoma
|
|
CN111368877A
|
|
Breast mass image enhancement identification method and device
|
|
CN111321914A
|
|
Infection source isolation device and isolation method
|
|
CN111206098A
|
|
Application of p38 gamma in preparation of pancreatic cancer prognosis diagnostic reagent
|
|
CN111228265A
|
|
Application of p38 gamma inhibitor in preparation of medicine for treating pancreatic cancer
|
